|
Newsletter
You can unsubscribe from this list
at any time by Clicking Here
and HITTING SEND. If you are having difficulty removing yourself
or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi.
Email : info@otcjournal.com
To OTC Journal Members: To thank you for your continued membership in the OTC Journal. We have just started a new Membership Value Points (MVP) Program. For each award period you are actively enrolled as a member, you will be issued points, which you can redeem for valuable rewards. Our first reward is an 13-issue subscription to Forbes Magazine. Your points are valid for 30 days, so to use them, they must be redeemed no later than April 1, 2000. There are no strings, no bills; this is not a promotional offer. It is a reward offered by us to you, in sincere thanks for your loyal membership in our newsletter. Please claim your reward by using the link below to redeem your points: Click
Here for 13 Issues Free Issues of Forbes
Disclaimer The OTCjournal.com Newsletter is an independent electronic publication committed to providing our readers with factual information on selected publicly traded companies. All companies are chosen on the basis of certain financial analysis and other pertinent criteria with a view toward maximizing the upside potential for investors while minimizing the downside risk, whenever possible. All statements and expressions are the sole opinions of the editors and are subject to change without notice. This profile is neither an offer nor solicitation to buy or sell any securities mentioned. This newsletter is owned by MarketByte LLC. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein. The editor, members of the editor's family, and/or entities with which they are affiliated, may own stock in and have other financial dealings with the companies who appear in the publication. To that degree, this newsletter should not be regarded to be an independent publication. The OTCjournal.com critiques may contain forward looking statements relating to the expected capabilities of the companies mentioned herein. THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com. We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission ("SEC") at http://www.sec.gov
and/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com.
We also strongly recommend that you read the SEC advisory to investors
concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Readers can review all public filings by companies at the SEC's EDGAR page.
The NASD has published information on how to invest carefully at its web
site.
You can unsubscribe from this list at any time by Clicking Here and HITTING SEND. If you are having difficulty removing yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi. |
To subscribe to our newsletter, please enter your email address below. Market Summary
|
|||||||||||||||||||||||


